Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dendritic Cells”

943 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 943 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05261750
What this trial is testing

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
PT. Prodia Stem Cell Indonesia 15
Not applicableUnknownNCT03753308
What this trial is testing

Mechanism of DCs Dysfunction in Chronic HBV Infection

Who this might be right for
HBVNASH - Nonalcoholic Steatohepatitis
University Hospital, Grenoble 132
Early research (Phase 1)UnknownNCT03282617
What this trial is testing

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer
National University Hospital, Singapore 55
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableUnknownNCT00327496
What this trial is testing

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Who this might be right for
Carcinoma, Hepatocellular
Mackay Memorial Hospital 10
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Large-scale testing (Phase 3)UnknownNCT00846157
What this trial is testing

Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
NKBio Co.Ltd. 276
Early research (Phase 1)Study completedNCT01171469
What this trial is testing

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Who this might be right for
Brain TumorGlioblastomaMedulloblastoma+2 more
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Large-scale testing (Phase 3)UnknownNCT06186986
What this trial is testing

CD30 Imaging in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphoma
University Medical Center Groningen 20
Not applicableLooking for participantsNCT07057765
What this trial is testing

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaMarkers of Inflammation
Ain Shams University 40
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Early research (Phase 1)Study completedNCT02479230
What this trial is testing

Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast Cancer
Joseph Baar, MD, PhD 18
Early research (Phase 1)Study completedNCT00798629
What this trial is testing

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 13
Not applicableUnknownNCT02325596
What this trial is testing

Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis

Who this might be right for
Rhinosinusitis
First Affiliated Hospital of Chongqing Medical University 70
Testing effectiveness (Phase 2)Study completedNCT00018954
What this trial is testing

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)WithdrawnNCT02662634
What this trial is testing

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
GU Research Network, LLC
Load More Results